Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
sNN0029 in ALS
NCT00800501Phase 2Completed
- Sponsor
- Newron Pharmaceuticals
- Start
- Dec 2008
- Primary completion
- Jun 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of telbermin in amyotrophic lateral sclerosis (ALS), sponsored by Newron Pharmaceuticals. Started Dec 2008; status: completed.
02
Drugs
telbermin
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00800501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00800501.